Glycosphingolipid functions.
暂无分享,去创建一个
[1] K. Sandhoff,et al. Lysosomal lipid storage diseases. , 2011, Cold Spring Harbor perspectives in biology.
[2] D. Lingwood,et al. Cholesterol modulates glycolipid conformation and receptor activity. , 2011, Nature chemical biology.
[3] C. Sweeley,et al. Glycosphingolipids: Structure, Biological Source, and Properties , 2010 .
[4] C. Ackerley,et al. A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins* , 2010, The Journal of Biological Chemistry.
[5] S. Munro,et al. A Comprehensive Comparison of Transmembrane Domains Reveals Organelle-Specific Properties , 2010, Cell.
[6] I. Vattulainen,et al. Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide. , 2010, The journal of physical chemistry. B.
[7] J. Lippincott-Schwartz,et al. Lipids and cholesterol as regulators of traffic in the endomembrane system. , 2010, Annual review of biophysics.
[8] J. Inokuchi. Membrane microdomains and insulin resistance , 2010, FEBS letters.
[9] E. Sidransky,et al. The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders , 2010, Current neurology and neuroscience reports.
[10] P. Moreau,et al. Glucosylceramide Biosynthesis is Involved in Golgi Morphology and Protein Secretion in Plant Cells , 2010, Traffic.
[11] K. Simons,et al. Structural basis of wedging the Golgi membrane by FAPP pleckstrin homology domains , 2010, EMBO reports.
[12] J. Fantini,et al. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. , 2010, Journal of molecular biology.
[13] A. Vedani,et al. Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluation. , 2010, Journal of medicinal chemistry.
[14] K. Gaus,et al. Actin Dynamics Drive Membrane Reorganization and Scission in Clathrin-Independent Endocytosis , 2010, Cell.
[15] J. Fantini,et al. How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ1-40) , 2010, PloS one.
[16] V. Gannon,et al. Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.
[17] Kai Simons,et al. Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.
[18] K. Simons,et al. Golgi protein FAPP2 tubulates membranes , 2009, Proceedings of the National Academy of Sciences.
[19] J. Langston,et al. Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. , 2009, Neurotoxicology.
[20] M. Cabot,et al. A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis , 2009, PloS one.
[21] C. Lingwood,et al. Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes , 2009, Journal of Lipid Research.
[22] N. Yuki,et al. Simultaneous immunohistochemical detection of gangliosides and neuronal markers in paraformaldehyde-fixed nervous tissues by acetone etching. , 2009, Archives of histology and cytology.
[23] K. Iwabuchi,et al. Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils , 2009, Glycoconjugate Journal.
[24] L. Johannes,et al. Lipid Reorganization Induced by Shiga Toxin Clustering on Planar Membranes , 2009, PloS one.
[25] P. Lin,et al. Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. , 2009, American journal of physiology. Heart and circulatory physiology.
[26] C. Lingwood,et al. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. , 2009, Kidney international.
[27] Kai Simons,et al. The Lipidomes of Vesicular Stomatitis Virus, Semliki Forest Virus, and the Host Plasma Membrane Analyzed by Quantitative Shotgun Mass Spectrometry , 2009, Journal of Virology.
[28] H. Fine,et al. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.
[29] K. Handa,et al. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines , 2009, Proceedings of the National Academy of Sciences.
[30] M. Langeveld,et al. Glycosphingolipids and insulin resistance. , 2009, Progress in lipid research.
[31] Zhenzhong Li,et al. The neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro , 2009, Brain Research Bulletin.
[32] P. Dubbelhuis,et al. Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation , 2009, PloS one.
[33] K. Itoh,et al. Tyrosine Kinase Activity of Epidermal Growth Factor Receptor Is Regulated by GM3 Binding through Carbohydrate to Carbohydrate Interactions* , 2009, Journal of Biological Chemistry.
[34] C. L. Jackson,et al. Mechanisms of transport through the Golgi complex , 2009, Journal of Cell Science.
[35] R. Pili,et al. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo , 2009, Glycoconjugate Journal.
[36] Takako Sasaki,et al. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth , 2009, Journal of Cell Science.
[37] C. Czerkinsky,et al. Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit , 2009, Scandinavian journal of immunology.
[38] T. Iwamoto,et al. Ganglioside GM1 Mediates Decapacitation Effects of SVS2 on Murine Spermatozoa1 , 2008, Biology of reproduction.
[39] T. Hennet,et al. The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo , 2008, BMC Developmental Biology.
[40] N. White,et al. cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[41] B. Binnington,et al. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. , 2008, Glycobiology.
[42] B. Binnington,et al. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide‐containing lipid assemblies , 2008, Journal of cellular physiology.
[43] Jyh‐cherng Yu,et al. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis , 2008, Proceedings of the National Academy of Sciences.
[44] M. Wiznitzer,et al. Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts. , 2008, Glycobiology.
[45] A. Giuliano,et al. A role for ceramide in driving cancer cell resistance to doxorubicin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] Robert D. Phair,et al. Transport through the Golgi Apparatus by Rapid Partitioning within a Two-Phase Membrane System , 2008, Cell.
[47] M. Pangalos,et al. Ganglioside Inhibition of Neurite Outgrowth Requires Nogo Receptor Function , 2008, Journal of Biological Chemistry.
[48] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[49] T. Obrig,et al. Immunohistologic techniques for detecting the glycolipid Gb3 in the mouse kidney and nervous system , 2008, Histochemistry and Cell Biology.
[50] M. Langeveld,et al. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[51] K. Iwabuchi,et al. Lyn‐coupled LacCer‐enriched lipid rafts are required for CD11b/CD18‐mediated neutrophil phagocytosis of nonopsonized microorganisms , 2008, Journal of leukocyte biology.
[52] A. Pandey,et al. The Yin and Yang of lactosylceramide metabolism: implications in cell function. , 2008, Biochimica et biophysica acta.
[53] S. Hakomori,et al. Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction. , 2008, Biochimica et biophysica acta.
[54] J. M. Aerts,et al. Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. , 2008, The Journal of clinical endocrinology and metabolism.
[55] S. Hakomori. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. , 2008, Biochimica et biophysica acta.
[56] T. Haga,et al. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157 , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[57] C. Ackerley,et al. Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog* , 2008, Journal of Biological Chemistry.
[58] Cheng Luo,et al. The Functional Roles of Lipid Rafts in T Cell Activation, Immune Diseases and HIV Infection and Prevention , 2008, Cellular and Molecular Immunology.
[59] Y. Kawai,et al. Genuine functions of P-glycoprotein (ABCB1). , 2008, Current drug metabolism.
[60] K. Murayama,et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils , 2008, Glycoconjugate Journal.
[61] P. Fratamico,et al. Characterization of Shiga Toxin-Producing Escherichia coli Isolates Associated with Two Multistate Food-Borne Outbreaks That Occurred in 2006 , 2007, Applied and Environmental Microbiology.
[62] Katharina Gaus,et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.
[63] I. Singh,et al. Lactosylceramide: a lipid second messenger in neuroinflammatory disease , 2007, Journal of neurochemistry.
[64] J. Fantini. Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. , 2007, Current medicinal chemistry.
[65] M. Latterich,et al. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum , 2007, Retrovirology.
[66] G. van Meer,et al. Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis , 2007, The Journal of cell biology.
[67] M. Doyle,et al. Food as a vehicle for transmission of Shiga toxin-producing Escherichia coli. , 2007, Journal of food protection.
[68] T. D. Connell,et al. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by Type I and Type II heat-labile enterotoxins , 2007, Expert review of vaccines.
[69] Y. Hannun,et al. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide , 2007, Nature.
[70] D. Lingwood,et al. Detergent resistance as a tool in membrane research , 2007, Nature Protocols.
[71] Y. Igarashi,et al. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[72] S. O’Rahilly,et al. Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity , 2007, Diabetes.
[73] Seng H. Cheng,et al. Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes , 2007, Diabetes.
[74] Jinjun Shi,et al. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. , 2007, Journal of the American Chemical Society.
[75] A. Schnitzler,et al. Induction of Cell Signaling Events by the Cholera Toxin B Subunit in Antigen-Presenting Cells , 2007, Infection and Immunity.
[76] R. Perlingeiro,et al. SSEA-4 identifies mesenchymal stem cells from bone marrow. , 2007, Blood.
[77] T. Schulz,et al. The Cell Surface Glycosphingolipids SSEA‐3 and SSEA‐4 Are Not Essential for Human ESC Pluripotency , 2007, Stem cells.
[78] M. Cabot,et al. Glycosphingolipids and drug resistance. , 2006, Biochimica et biophysica acta.
[79] T. Hikita,et al. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor , 2006, Proceedings of the National Academy of Sciences.
[80] E. Gazit,et al. The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain , 2006, The FEBS journal.
[81] R. Abagyan,et al. The Liganding of Glycolipid Transfer Protein Is Controlled by Glycolipid Acyl Structure , 2006, PLoS biology.
[82] S. V. van IJzendoorn,et al. Efficient trafficking of MDR1/P-glycoprotein to apical canalicular plasma membranes in HepG2 cells requires PKA-RIIalpha anchoring and glucosylceramide. , 2006, Molecular biology of the cell.
[83] K. Kaibuchi,et al. Myelin-associated Glycoprotein Inhibits Microtubule Assembly by a Rho-kinase-dependent Mechanism* , 2006, Journal of Biological Chemistry.
[84] Chiou-Feng Lin,et al. Ceramide in apoptotic signaling and anticancer therapy. , 2006, Current medicinal chemistry.
[85] J. Medin,et al. Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1 , 2006, The FEBS journal.
[86] Kazuro Furukawa,et al. Targeted Disruption of Gb3/CD77 Synthase Gene Resulted in the Complete Deletion of Globo-series Glycosphingolipids and Loss of Sensitivity to Verotoxins* , 2006, Journal of Biological Chemistry.
[87] I. Wilson,et al. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[88] John R. Riordan,et al. Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking , 2006, Journal of Cell Science.
[89] R. Blumenthal,et al. A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection , 2006, AIDS.
[90] M. Bennish,et al. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[91] M. Del Poeta,et al. Role of Sphingolipids in Microbial Pathogenesis , 2006, Infection and Immunity.
[92] L. Johannes,et al. Article Title: the Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect the Association of Shiga-like Toxin with Detergent- Resistant Membranes Is Modulated by Glucosylc , 2022 .
[93] R. Brady,et al. Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus , 2005, AIDS.
[94] K. Sandvig,et al. The A‐subunit of surface‐bound Shiga toxin stimulates clathrin‐dependent uptake of the toxin , 2005, The FEBS journal.
[95] S. Stice,et al. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces , 2005, BMC Developmental Biology.
[96] F. Sharom,et al. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. , 2005, The Biochemical journal.
[97] S. Krämer,et al. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells , 2005, In Vitro Cellular & Developmental Biology - Animal.
[98] T. D. Connell,et al. Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells , 2005, Infection and Immunity.
[99] J. Paulson,et al. Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro* , 2005, Journal of Biological Chemistry.
[100] I. Singh,et al. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. , 2005, The Journal of biological chemistry.
[101] David L. Swerdlow,et al. Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002 , 2005, Emerging infectious diseases.
[102] Manuel Prieto,et al. Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study. , 2005, Journal of molecular biology.
[103] R. Proia,et al. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[104] M. Schlossmacher,et al. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2005, The New England journal of medicine.
[105] E. Ikonen,et al. Lipid Microdomains and Insulin Resistance: Is There a Connection? , 2005, Science's STKE.
[106] Perttu S. Niemelä,et al. Structure and dynamics of sphingomyelin bilayer: insight gained through systematic comparison to phosphatidylcholine. , 2004, Biophysical journal.
[107] R. Dwek,et al. Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis. , 2004, The Biochemical journal.
[108] R. Dwek,et al. Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C , 2004, Neurobiology of Disease.
[109] N. White,et al. Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. , 2004, American journal of respiratory cell and molecular biology.
[110] Peter Strålfors,et al. Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. , 2004, European journal of biochemistry.
[111] M. Gottesman,et al. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. , 2004, Molecular cancer therapeutics.
[112] I. Mills,et al. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. , 2004, Developmental cell.
[113] C. Ackerley,et al. Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis* , 2004, Journal of Biological Chemistry.
[114] K. Ravichandran,et al. Human Immunodeficiency Virus Type 1 Nef Associates with Lipid Rafts To Downmodulate Cell Surface CD4 and Class I Major Histocompatibility Complex Expression and To Increase Viral Infectivity , 2004, Journal of Virology.
[115] Y. Wada,et al. Sulfatide is a negative regulator of oligodendrocyte differentiation: Development in sulfatide‐null mice , 2004, Glia.
[116] J. Pettegrew,et al. Alzheimer's Disease: NMR Studies of Asialo (GM1) and Trisialo (GT1b) Ganglioside Interactions with Aβ(1-40) Peptide in a Membrane Mimic Environment , 2004, Neurochemical Research.
[117] A. Verkman,et al. CFTR pharmacology and its role in intestinal fluid secretion. , 2003, Current opinion in pharmacology.
[118] R. Steffensen,et al. Two Distinct Gb3/CD77 Signaling Pathways Leading to Apoptosis Are Triggered by Anti-Gb3/CD77 mAb and Verotoxin-1* , 2003, Journal of Biological Chemistry.
[119] U. Buchholz,et al. Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[120] T. Wada,et al. Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase* , 2003, Journal of Biological Chemistry.
[121] I. Wilson,et al. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å , 2003, Nature Immunology.
[122] V. Puri,et al. Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage* , 2003, Journal of Biological Chemistry.
[123] R. Pagano. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[124] G. Hoser,et al. Structure of the ceramide moiety of GM1 ganglioside determines its occurrence in different detergent-resistant membrane domains in HL-60 cells. , 2003, Biochemistry.
[125] T. Yutsudo,et al. Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells , 2003, Infection and Immunity.
[126] L. Johannes,et al. Effects of HIV‐1 Nef on Retrograde Transport from the Plasma Membrane to the Endoplasmic Reticulum , 2003, Traffic.
[127] P. Loll. Membrane protein structural biology: the high throughput challenge. , 2003, Journal of structural biology.
[128] R. Proia,et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[129] C. Haass,et al. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.
[130] R. Proia,et al. Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis. , 2002, Biochimica et biophysica acta.
[131] C. Bandtlow,et al. Nogo-A and Myelin-Associated Glycoprotein Mediate Neurite Growth Inhibition by Antagonistic Regulation of RhoA and Rac1 , 2002, The Journal of Neuroscience.
[132] R. Dwek,et al. Glucosylceramide modulates membrane traffic along the endocytic pathway Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200232-JLR200 , 2002, Journal of Lipid Research.
[133] J. Fantini,et al. A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction DOI 10.1194/jlr.M200165-JLR200 , 2002, Journal of Lipid Research.
[134] M. Schachner,et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[135] W. Au,et al. Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry into CD4+ T Cells , 2002, Journal of Virology.
[136] D. Acheson,et al. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy , 2002, Pediatric Nephrology.
[137] J. Fantini,et al. Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins* , 2002, The Journal of Biological Chemistry.
[138] K. Fukushima,et al. Paranodal junction formation and spermatogenesis require sulfoglycolipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[139] M. Jobling,et al. Mutational Analysis of Ganglioside GM1-Binding Ability, Pentamer Formation, and Epitopes of Cholera Toxin B (CTB) Subunits and CTB/Heat-Labile Enterotoxin B Subunit Chimeras , 2002, Infection and Immunity.
[140] C. MacKenzie,et al. A Mutational Analysis of the Globotriaosylceramide-binding Sites of Verotoxin VT1* , 2002, The Journal of Biological Chemistry.
[141] D. Kabat,et al. Segregation of CD4 and CXCR4 into Distinct Lipid Microdomains in T Lymphocytes Suggests a Mechanism for Membrane Destabilization by Human Immunodeficiency Virus , 2002, Journal of Virology.
[142] Y. Igarashi,et al. Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance* , 2002, The Journal of Biological Chemistry.
[143] T. Suzuki,et al. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide. , 2001, The Tohoku journal of experimental medicine.
[144] E. Freed,et al. Plasma membrane rafts play a critical role in HIV-1 assembly and release , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[145] H Nakajima,et al. Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.
[146] B. Westerink,et al. UvA-DARE ( Digital Academic Repository ) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex , 2001 .
[147] Yoshimasa Kinoshita,et al. Toxicity of Shiga Toxin 1 in the Central Nervous System of Rabbits , 2001, Infection and Immunity.
[148] P. Ray,et al. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome , 2001, Pediatric Nephrology.
[149] A. Abe,et al. Agents for the treatment of glycosphingolipid storage disorders. , 2001, Current drug metabolism.
[150] J. Salamero,et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.
[151] Dzung H. Nguyen,et al. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. , 2001, AIDS research and human retroviruses.
[152] G. Millat,et al. Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations , 2001, Human Genetics.
[153] S. Wied,et al. Redistribution of Glycolipid Raft Domain Components Induces Insulin-Mimetic Signaling in Rat Adipocytes , 2001, Molecular and Cellular Biology.
[154] J. Lippincott-Schwartz,et al. Rapid Cycling of Lipid Raft Markers between the Cell Surface and Golgi Complex , 2001, The Journal of cell biology.
[155] A. Zurita,et al. Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. , 2001, The Biochemical journal.
[156] A. Giuliano,et al. Ceramide glycosylation potentiates cellular multidrug resistance , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[157] T. Suzuki,et al. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. , 2000, Experimental hematology.
[158] C. Martínez-A,et al. Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.
[159] T. Hikita,et al. Requirement of Seminolipid in Spermatogenesis Revealed by UDP-galactose:Ceramide Galactosyltransferase-deficient Mice* , 2000, The Journal of Biological Chemistry.
[160] Dzung H. Nguyen,et al. Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.
[161] R. Dwek,et al. N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. , 2000, Biochemical pharmacology.
[162] V. Herzog,et al. Cholera Toxin Is Exported from Microsomes by the Sec61p Complex , 2000, The Journal of cell biology.
[163] C. Lingwood,et al. Retroviral Transfection of Madin-Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-Fold Increased Cell Sensitivity to Verocytotoxin , 2000, The Journal of Biological Chemistry.
[164] M. Kuriyama,et al. Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells) , 2000, Glycoconjugate Journal.
[165] J. Fantini,et al. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion , 2000, Glycoconjugate Journal.
[166] Y. Sanai,et al. Functional roles of glycosphingolipids in signal transduction via lipid rafts , 2000, Glycoconjugate Journal.
[167] J. Boggs,et al. Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers. , 2000, Biophysical journal.
[168] A. Saltiel,et al. Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.
[169] Tetsuya Mori,et al. Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains* , 1999, The Journal of Biological Chemistry.
[170] G. Kopf,et al. Cholesterol efflux-mediated signal transduction in mammalian sperm: cholesterol release signals an increase in protein tyrosine phosphorylation during mouse sperm capacitation. , 1999, Developmental biology.
[171] V. Puri,et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases , 1999, Nature Cell Biology.
[172] M. Patterson,et al. Broad screening test for sphingolipid-storage diseases , 1999, The Lancet.
[173] J. Sodroski,et al. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. , 1999, Biochemistry.
[174] J. Fantini,et al. Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3) , 1999, Journal of Virology.
[175] D. Acheson,et al. Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis , 1999, Infection and Immunity.
[176] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[177] S. Siziya,et al. Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe. , 1998, The Central African journal of medicine.
[178] J. Slot,et al. UDP-Galactose:Ceramide Galactosyltransferase Is a Class I Integral Membrane Protein of the Endoplasmic Reticulum* , 1998, The Journal of Biological Chemistry.
[179] J. Schneider. GM1 Ganglioside in the Treatment of Parkinson's Disease a , 1998 .
[180] James L. Madara,et al. Ganglioside Structure Dictates Signal Transduction by Cholera Toxin and Association with Caveolae-like Membrane Domains in Polarized Epithelia , 1998, The Journal of cell biology.
[181] J. Fantini,et al. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. , 1998, Biochemical and biophysical research communications.
[182] A. Ljungh,et al. The lactosylceramide binding specificity of Helicobacter pylori. , 1998, Glycobiology.
[183] A. Stringaro,et al. Detection of P‐glycoprotein in the Golgi apparatus of drug‐untreated human melanoma cells , 1998, International journal of cancer.
[184] A. Blight,et al. Myelin Galactolipids Are Essential for Proper Node of Ranvier Formation in the CNS , 1998, The Journal of Neuroscience.
[185] B. Popko,et al. New perspectives on the function of myelin galactolipids , 1998, Trends in Neurosciences.
[186] Y. Ihara,et al. GM1 Ganglioside-Bound Amyloid β-Protein in Alzheimer’s Disease Brain , 1998, Neurobiology of Aging.
[187] R J Read,et al. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.
[188] R. Lal,et al. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. , 1998, Virology.
[189] J. Fantini,et al. Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 gp120 and Inhibit HIV-1-induced Fusion and Entry* , 1997, The Journal of Biological Chemistry.
[190] K. Karlsson,et al. Screening for the presence of polyglycosylceramides in various tissues: partial characterization of blood group-active complex glycosphingolipids of rabbit and dog small intestines , 1997, Glycoconjugate Journal.
[191] J. Fantini,et al. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. , 1996, Biochemistry.
[192] Joseph Sodroski,et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.
[193] K. Takamiya,et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[194] C. Lingwood. Aglycone modulation of glycolipid receptor function , 1996, Glycoconjugate Journal.
[195] A. Blight,et al. Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability , 1996, Cell.
[196] J. Boggs,et al. Study by infrared spectroscopy of the interdigitation of C26:0 cerebroside sulfate into phosphatidylcholine bilayers. , 1996, Biochemistry.
[197] T. Koerner,et al. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. , 1995, The Journal of infectious diseases.
[198] S. Hakomori,et al. Galactosylgloboside expression in seminoma. Inverse correlation with metastatic potential , 1995, Cancer.
[199] M. Hamaguchi,et al. Ganglioside GM1 binds to the Trk protein and regulates receptor function. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[200] P. Spitalnik,et al. The P blood group system: biochemical, serological, and clinical aspects. , 1995, Transfusion medicine reviews.
[201] S. Lawson,et al. Substance P, neurofilament, peripherin and SSEA4 immunocytochemistry of human dorsal root ganglion neurons obtained from post-mortem tissue: a quantitative morphometric analysis , 1994, Journal of neurocytology.
[202] C. Lingwood,et al. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. , 1994, The Journal of biological chemistry.
[203] F. Wieland,et al. Lactosylceramide is synthesized in the lumen of the Golgi apparatus , 1994, FEBS letters.
[204] H. Jarrell,et al. Acyl chain length effects related to glycosphingolipid crypticity in phospholipid membranes: probed by 2H-NMR. , 1994, Biochimica et biophysica acta.
[205] J. Martial,et al. Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.
[206] S. Hakomori,et al. GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. , 1994, The Journal of biological chemistry.
[207] J. Boggs,et al. Do the long fatty acid chains of sphingolipids interdigitate across the center of a bilayer of shorter chain symmetric phospholipids? , 1994, Biochimica et biophysica acta.
[208] K. Karlsson,et al. New method for the isolation of polyglycosylceramides from human erythrocyte membranes. , 1993, Biochimica et biophysica acta.
[209] G. Guroff,et al. The Effect of the B Subunit of Cholera Toxin on the Action of Nerve Growth Factor on PC12 Cells , 1993, Journal of neurochemistry.
[210] J. Fantini,et al. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[211] D. Weiner,et al. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. , 1993, AIDS research and human retroviruses.
[212] H. Moreau,et al. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells , 1992, Journal of virology.
[213] P. Fishman,et al. Intoxication of cultured cells by cholera toxin: evidence for different pathways when bound to ganglioside GM1 or neoganglioproteins. , 1992, Biochemistry.
[214] F. Wieland,et al. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions , 1992, The Journal of cell biology.
[215] A. Abe,et al. Improved inhibitors of glucosylceramide synthase. , 1992, The Journal of biological chemistry.
[216] R. Pagano,et al. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. , 1991, The Biochemical journal.
[217] D. Silberberg,et al. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[218] P. Fishman,et al. Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. , 1991, Biochemistry.
[219] K. Karlsson,et al. Characterization of the binding of propionibacterium granulosum to glycosphingolipids adsorbed on surfaces. An apparent recognition of lactose which is dependent on the ceramide structure. , 1990, The Journal of biological chemistry.
[220] H. Jarrell,et al. Glycosphingolipid interdigitation in phospholipid bilayers examined by deuterium NMR and EPR. , 1990, Biochimica et biophysica acta.
[221] J. Boggs,et al. Dependence of the surface expression of the glycolipid cerebroside sulfate on its lipid environment: comparison of sphingomyelin and phosphatidylcholine. , 1990, Biochemistry.
[222] N. Radin,et al. Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells , 1989, Journal of cellular physiology.
[223] L. Wolpert. Positional information revisited. , 1989, Development.
[224] P. Oteiza,et al. Inhibition of the synthesis of glycosphingolipids affects the translocation of proteolipid protein to the myelin membrane , 1989, Journal of neuroscience research.
[225] S. Saxena,et al. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. , 1989, The Journal of biological chemistry.
[226] I. Pascher,et al. On the dissection of binding epitopes on carbohydrate receptors for microbes using molecular modelling. , 1988, Biochimie.
[227] A. Ullrich,et al. Biological activities of EGF‐receptor mutants with individually altered autophosphorylation sites. , 1988, The EMBO journal.
[228] S. Hakomori,et al. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. , 1988, The Journal of biological chemistry.
[229] P. Andrews. Human teratocarcinoma stem cells: Glycolipid antigen expression and modulation during differentiation , 1987, Journal of cellular biochemistry.
[230] G van Meer,et al. Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells , 1987, The Journal of cell biology.
[231] D. Solter,et al. Detection of SSEA‐1 on human renal tumors , 1987, Cancer.
[232] F. Inagaki,et al. A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney. , 1987, Journal of biochemistry.
[233] J. Boggs,et al. Factors affecting surface expression of glycolipids: influence of lipid environment and ceramide composition on antibody recognition of cerebroside sulfate in liposomes. , 1986, Biochemistry.
[234] C. Lingwood. Timing of sulphogalactolipid biosynthesis in the rat testis studied by tissue autoradiography. , 1985, Journal of cell science.
[235] T. Jessell,et al. Structure and expression of differentiation antigens on functional subclasses of primary sensory neurons , 1985, Philosophical Transactions of the Royal Society of London. B, Biological Sciences.
[236] S. Hakomori,et al. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. , 1984, The Journal of biological chemistry.
[237] D. Solter,et al. Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.
[238] S. Hakomori,et al. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. , 1983, Cancer research.
[239] E. Carey,et al. UDP‐Galactose:Ceramide Galactosyl Transferase of Isolated Oligodendroglia , 1983, Journal of neurochemistry.
[240] S. Hakomori,et al. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. , 1982, The Journal of biological chemistry.
[241] D. Solter,et al. Murine embryonic antigen (SSEA-1) is expressed on human cells and structurally related human blood group antigen I is expressed on mouse embryos. , 1982, Developmental biology.
[242] D. Solter,et al. Monoclonal antibody against SSEA-1 is specific for a subpopulation of astrocytes in mouse cerebellum , 1982, Neuroscience Letters.
[243] D. Solter,et al. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. , 1982, The American journal of pathology.
[244] S. Hakomori,et al. Possible role of ceramide in defining structure and function of membrane glycolipids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[245] D. Solter,et al. A murine stage-specific embryonic antigen (SSEA-2) is expressed on some murine SV40-transformed cells. , 1981, Journal of Immunology.
[246] D. Solter,et al. Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. , 1981, Developmental biology.
[247] D. Solter,et al. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[248] D. Gill,et al. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[249] I. Pascher,et al. Molecular arrangements in sphingolipids. The crystal structure of cerebroside , 1977 .
[250] S. Hakomori,et al. Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. , 1977, Experimental cell research.
[251] Gill Dm. The arrangement of subunits in cholera toxin. , 1976 .
[252] D. Summerbell,et al. Positional signalling and specification of digits in chick limb morphogenesis , 1975, Nature.
[253] S. Heyningen,et al. Cholera Toxin: Interaction of Subunits with Ganglioside GM1 , 1974 .
[254] 김종선. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft , 2009 .
[255] R. McElhaney,et al. Calorimetric and spectroscopic studies of the effects of cholesterol on the thermotropic phase behavior and organization of a homologous series of linear saturated phosphatidylglycerol bilayer membranes. , 2009, Biochimica et biophysica acta.
[256] P. Galle,et al. The longevity assurance homologue of yeast lag1 (Lass) gene family (review). , 2009, International journal of molecular medicine.
[257] K. Murayama,et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils , 2008, Glycoconjugate Journal.
[258] L. Johannes,et al. The secretion inhibitor Exo 2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network , 2008 .
[259] W. Lencer,et al. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. , 2007, FEMS microbiology letters.
[260] A. Varki,et al. Siglecs--the major subfamily of I-type lectins. , 2006, Glycobiology.
[261] Xianlin Han. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. , 2005, Current Alzheimer research.
[262] C. Lingwood,et al. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker , 2004, Angiogenesis.
[263] C. Lingwood,et al. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody. , 2004, European journal of biochemistry.
[264] T. Muramatsu,et al. Carbohydrate antigens expressed on stem cells and early embryonic cells , 2004, Glycoconjugate Journal.
[265] R. Proia,et al. A vital role for glycosphingolipid synthesis during development and differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[266] M. Foti,et al. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. , 1997, Immunity.
[267] L. Greene,et al. Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: insights and speculations regarding a common mechanism. , 1996, Perspectives on developmental neurobiology.
[268] Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. , 1991, Disease markers.
[269] M. Ferguson,et al. Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. , 1988, Annual review of biochemistry.
[270] S. Hakomori. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.
[271] L Orci,et al. Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[272] A. Kahn,et al. The Cell Surface , 1974, Advances in Experimental Medicine and Biology.